Product-Specific Guidance Revisions: Update on Metered Dose Inhaler & Dry Powder InhalerBack to: Advancing Generic Drug Development 2025 Previous LessonSME Triage Team Case Study: Complex Implant Products – Excipient Sameness, Characterization and Bioequivalence ChallengesLesson 2 within section Session 1: Insights to Product-Specific Guidance for Complex Products: From Research to Standards. Next LessonStreamlining Recommendations for Topical and Mucosal ProductsLesson 4 within section Session 1: Insights to Product-Specific Guidance for Complex Products: From Research to Standards. Presenter Liangfeng Han, MD, PhDClinical AnalystDTPI | ORS | OGD | CDER | FDA Leave a Comment Cancel replyLogin with your Social IDYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. Δ